CBDD.US Cbd of Denver Inc

Healthcare Internet & Direct Marketing Retail USA Stocks
0.0001 USD
Close of Nov 11, 2026
Market cap
USD 1.11M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is CBDD.US undervalued?

Graham number

The Graham number of Cbd of Denver Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cbd of Denver Inc fundamental analysis

No fundamental analysis for Cbd of Denver Inc yet.

Cbd of Denver Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cbd of Denver Inc

CBD of Denver Inc. engages in developing and commercializing cannabidiol (CBD) products. It is involved in the research, development, and distribution of premium hemp extract products. The company was formerly known as Verde Media Group, Inc. and changed its name to CBD of Denver Inc. in 2018. CBD of Denver Inc. is based in Dietlikon, Switzerland. CBD of Denver Inc. operates as a subsidiary of Swiss Industry Ventures AG.

Full company profile